Revenue (Quarterly) Chart

View Revenue (Quarterly) for AFGVF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (Quarterly) Chart
Start Trial

Historical Revenue (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 319.75M
March 31, 2026 276.10M
December 31, 2025 356.16M
September 30, 2025 300.34M
June 30, 2025 318.50M
March 31, 2025 254.70M
December 31, 2024 346.68M
September 30, 2024 304.30M
June 30, 2024 307.89M
March 31, 2024 271.34M
December 31, 2023 336.61M
September 30, 2023 304.59M
June 30, 2023 312.35M
March 31, 2023 289.69M
December 31, 2022 322.13M
September 30, 2022 292.11M
June 30, 2022 305.86M
March 31, 2022 282.70M
December 31, 2021 553.22M
September 30, 2021 517.46M
June 30, 2021 531.68M
March 31, 2021 476.98M
December 31, 2020 556.75M
September 30, 2020 479.21M
June 30, 2020 436.10M
Date Value
March 31, 2020 479.23M
December 31, 2019 585.68M
September 30, 2019 542.58M
June 30, 2019 558.45M
March 31, 2019 594.98M
December 31, 2018 669.81M
September 30, 2018 626.93M
June 30, 2018 665.70M
March 31, 2018 674.72M
December 31, 2017 753.50M
September 30, 2017 695.99M
June 30, 2017 684.48M
March 31, 2017 626.70M
December 31, 2016 715.56M
September 30, 2016 697.56M
June 30, 2016 728.30M
March 31, 2016 664.81M
December 31, 2015 735.51M
September 30, 2015 734.70M
June 30, 2015 764.41M
March 31, 2015 699.24M
December 31, 2014 888.14M
September 30, 2014 842.60M
June 30, 2014 892.69M
March 31, 2014 852.25M

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Quarterly) Range, Past 5 Years

View Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Quarterly) Benchmarks

View Revenue (Quarterly) Benchmarks
Start Trial
Biotricity, Inc. 4.277M
Ion Beam Applications SA --
Nyxoah SA 8.924M
Ascom Holding AG --
Aclarion, Inc. 0.0252M